(Q83362605)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16706558%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Insulin glulisine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16706558%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16706558%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Keri Wellington

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16706558%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16706558%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16706558%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16706558%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16706558%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

861-869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16706558%20AND%20SRC:MED&resulttype=core&format=json

A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1.

21 January 2020

cites work

1 reference

12 December 2020

Insulin glulisine: insulin receptor signaling characteristics in vivo

1 reference

12 December 2020

Efficacy and safety of insulin glulisine in patients with type 1 diabetes

1 reference

12 December 2020

Insulin glargine: an updated review of its use in the management of diabetes mellitus

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes

1 reference

12 December 2020

Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors

1 reference

12 December 2020

Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus

1 reference

12 December 2020

Insulin glulisine provides improved glycemic control in patients with type 2 diabetes

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique

1 reference

12 December 2020

Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus

1 reference

12 December 2020

Optimized Basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with Basal insulin glargine

1 reference

12 December 2020

LysB3, GluB29 insulin: a novel insulin analog with enhanced β-cell protective action

1 reference

12 December 2020

Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects

1 reference

12 December 2020

Recombinant DNA technology in the treatment of diabetes: insulin analogs

1 reference

12 December 2020

Insulin administration

1 reference

12 December 2020